Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Vincent Meunier
Vincent Meunier
Stock Analyst at Morgan Stanley
(1.07)
# 3,522
Out of 4,711 analysts
9
Total ratings
33.33%
Success rate
-4.48%
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - General
Stocks Rated by Vincent Meunier
Stock
Action
Price Target
Current
Upside
Ratings
Updated
NVS
Novartis AG
Upgrades:
Equal-Weight
n/a
$97.11
-
7
Sep 25, 2023
NVO
Novo Nordisk
Initiates:
Equal-Weight
n/a
$85.00
-
2
Dec 14, 2018
NVS
Novartis AG
Sep 25, 2023
Upgrades:
Equal-Weight
Price Target:
n/a
Current: $97.11
Upside: -
7 Ratings
View All
NVO
Novo Nordisk
Dec 14, 2018
Initiates:
Equal-Weight
Price Target:
n/a
Current: $85.00
Upside: -
2 Ratings
View All